We are live on
!
Find out more
KCM
Knoll Capital Management Portfolio holdings
AUM
$180M
1-Year Est. Return
66.11%
This Fund
S&P 500
This Quarter
Est. Return
+24.56%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$44.3M
AUM Growth
-$127M
(-74%)
Cap. Flow
-$68.9M
Cap. Flow
% of AUM
-155.44%
Top 10 Holdings %
Top 10 Hldgs %
83.03%
Holding
39
New
6
Increased
2
Reduced
3
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$2.46M |
| 2 |
Global X Silver Miners ETF NEW
SIL
|
+$2.41M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$1.75M |
| 4 |
VRNA
Verona Pharma
VRNA
|
+$1.27M |
| 5 |
APLT
Applied Therapeutics
APLT
|
+$1.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$68.4M |
| 2 |
Corbus Pharmaceuticals
CRBP
|
+$833K |
| 3 |
Corning
GLW
|
+$773K |
| 4 |
Agnico Eagle Mines
AEM
|
+$650K |
| 5 |
MAG
MAG Silver
MAG
|
+$599K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 69.17% |
| 2 | Financials | 3.95% |
| 3 | Industrials | 3.07% |
| 4 | Materials | 2.54% |
| 5 | Consumer Staples | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Equinox Gold
EQX
$13.5B
| – | – |
-99,000
| Closed | -$361K |
|
27
Franco-Nevada
FNV
$46B
| – | – |
-4,900
| Closed | -$585K |
|
|
28
Corning
GLW
$143B
| – | – |
-26,600
| Closed | -$773K |
|
|
MAG
29
DELISTED
MAG Silver
MAG
| – | – |
-48,000
| Closed | -$599K |
|
30
Oramed Pharmaceuticals
ORMP
$179M
| – | – |
-20,000
| Closed | -$130K |
|
31
Pan American Silver
PAAS
$21.6B
| – | – |
-29,500
| Closed | -$468K |
|
32
Soligenix
SNGX
$5.81M
| – | – |
-145
| Closed | -$15K |
|
33
Wheaton Precious Metals
WPM
$60.9B
| – | – |
-16,500
| Closed | -$534K |
|
|
SILV
34
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
| – | – |
-100,000
| Closed | -$553K |
|
|
EIGR
35
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| – | – |
-19,532
| Closed | -$586K |
|
|
MRTX
36
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-5,000
| Closed | -$349K |
|
|
MMX
37
DELISTED
Maverix Metals Inc. Common Shares
MMX
| – | – |
-165,000
| Closed | -$553K |
|
Similar funds
FBC
AIC
AG
PCA
HIC
FFA
V
RVM
Knoll Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Knoll Capital Management held 39 positions worth $44.3M, down 74% from $171M the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Knoll Capital Management withdrew a net $68.9M in Q4 2022, closing 18 positions and reducing 3 holdings. Its most notable exit was Corbus Pharmaceuticals, an estimated $833K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 92% a quarter earlier, followed by Financials and Industrials.
Against the trend, Knoll Capital Management opened a new position in VanEck Gold Miners ETF worth $2.63M.
- Knoll Capital Management's largest Q4 2022 buy was VanEck Gold Miners ETF: 91,850 shares worth $2.63M.
- Knoll Capital Management added most to Applied Therapeutics in Q4 2022, an estimated $1.08M increase.
- Knoll Capital Management's biggest Q4 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $68.4M.
- Knoll Capital Management fully exited Corbus Pharmaceuticals in Q4 2022, selling an estimated $833K.
- Knoll Capital Management's ten largest holdings make up 83% of its $44.3M portfolio in Q4 2022.
- Knoll Capital Management opened 6 new positions and closed 18 in Q4 2022.
- Knoll Capital Management's portfolio value fell 74% quarter-over-quarter to $44.3M.
Based on Knoll Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.